Evergreen Capital Management
PBYI icon

Evergreen Capital Management’s Puma Biotechnology PBYI Stock Holding History

Evergreen Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$732K Sell
73,672
-59
-0.1% -$519 0.01% 650
2026
Q2 		$598K Sell
73,731
-22,269
-23% -$163K 0.01% 802
2026
Q1 		$613K Hold
96,000
– – 0.01% 667
2025
Q4 		$571K Hold
96,000
– – 0.01% 671
2025
Q3 		$510K Hold
96,000
– – 0.01% 652
2025
Q2 		$329K Buy
+96,000
New +$306K 0.01% 757

Other funds holding PBYI

Haven Private
Haven Private Orlando, Florida $253M AUM 14.52% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Baron Wealth Management
Baron Wealth Management Troy, Michigan $389M AUM 21.95% 1-Year Est. Return
C2C Wealth Management
C2C Wealth Management Scottsdale, Arizona $128M AUM 19.37% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Evergreen Capital Management's PBYI Position: Q3 2026 in Review

Evergreen Capital Management reduced its Puma Biotechnology (PBYI) stake by 0.08% in Q3 2026, selling an estimated $519 and leaving 73,672 shares worth $732K. The position accounts for 0.01% of the portfolio, ranked #650.

Evergreen Capital Management first reported a position in PBYI in Q2 2025 and has held it in 6 quarters since. 36 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Evergreen Capital Management held 73,672 shares of Puma Biotechnology worth $732K as of Q3 2026.
  • Evergreen Capital Management sold 59 Puma Biotechnology shares in Q3 2026, an estimated $519.
  • Puma Biotechnology made up 0.01% of Evergreen Capital Management's portfolio in Q3 2026, its #650 holding.
  • Evergreen Capital Management first reported a position in Puma Biotechnology in Q2 2025 and has held it in 6 quarters since.
  • 36 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Evergreen Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.